Article Figures & Data
Figures
- Figure 1.
Itch Severity Item Score Showed Rapid Improvement With Tofacitinib
BIW, twice weekly; ISI, Itch Severity Item; LS, least squares; SC, subcutaneous; SE, Standard error.
a P <.05 vs placebo; b P <.0001 vs placebo; c P <.05 vs etanercept; d P <.001 vs etanercept; e P <.0001 vs etanercept.
Reproduced with permission from F Valenzuela, MD.
- Figure 2.
Dermatology Life Quality Index Score Improved With Tofacitinib
BIW, twice weekly; DLQI, Dermatology Life Quality Index; LS, least squares; SC, subcutaneous; SE, standard error.
a P <.05 vs placebo; b P <.0001 vs placebo; c P <.05 vs etanercept; d P <.001 vs etanercept.
Reproduced with permission from F Valenzuela, MD.
Tools
Health-Related QOL Improved with Tofacitinib in Patients with Psoriasis
Permalink:
Table of contents
Cited By...
- No citing articles found.